BlackRock Fund Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$61.8M Buy
1,631,500
+589,020
+57% +$22.3M 0.01% 1547
2016
Q3
$39.3M Buy
1,042,480
+70,584
+7% +$1.56M 0.01% 1735
2016
Q2
$17.1M Buy
971,896
+92,113
+10% +$1.49M ﹤0.01% 2112
2016
Q1
$10.7M Buy
879,783
+17,704
+2% +$280K ﹤0.01% 2304
2015
Q4
$21M Sell
862,079
-44,088
-5% -$1.03M ﹤0.01% 2013
2015
Q3
$16.1M Buy
906,167
+36,518
+4% +$661K ﹤0.01% 2135
2015
Q2
$15.3M Buy
869,649
+271,357
+45% +$4.97M ﹤0.01% 2273
2015
Q1
$18.8M Buy
598,292
+24,620
+4% +$714K ﹤0.01% 2112
2014
Q4
$16.7M Buy
573,672
+324,574
+130% +$8.23M ﹤0.01% 2167
2014
Q3
$5.15M Sell
249,098
-6,223
-2% -$123K ﹤0.01% 2738
2014
Q2
$6.32M Buy
255,321
+34,198
+15% +$592K ﹤0.01% 2698
2014
Q1
$4.69M Buy
221,123
+15,030
+7% +$304K ﹤0.01% 2866
2013
Q4
$3.7M Buy
+206,093
New +$2.68M ﹤0.01% 2983

Other funds holding AERI